Should You Dispose Your ACADIA Pharmaceuticals (ACAD) Position?
Alger, an investment management firm, published its “Alger Weatherbie Specialized Growth Fund” first quarter 2021 investor letter – a copy of which...
Posts Tagged ‘NASDAQ:ACAD’
Is ACADIA Pharmaceuticals (ACAD) Stock A Buy or Sell?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data....
Is ACAD A Good Stock To Buy Now?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers...
Were Hedge Funds Wrong About Embracing ACADIA Pharmaceuticals Inc. (ACAD)?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed...
Hedge Funds Never Been This Bullish On ACADIA Pharmaceuticals Inc. (ACAD)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data....
Did Hedge Funds Make The Right Call On ACADIA Pharmaceuticals Inc. (ACAD) ?
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors...
Why Acadia Pharmaceuticals (ACAD) Stock is a Compelling Investment Case
If you are looking for the best ideas for your portfolio you may want to consider some of Mott Capital’s top stock picks. Mott Capital, an investment...
Hedge Funds Are Selling ACADIA Pharmaceuticals Inc. (ACAD)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (...
Hedge Funds Have Never Been This Bullish On ACADIA Pharmaceuticals Inc. (ACAD)
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted...
How Did ACADIA Pharmaceuticals Inc. (ACAD) Perform In Comparison to Hedge Fund Favorites in 2019?
Hedge funds are known to underperform the bull markets but that’s not because they are bad at investing. Truth be told, most hedge fund managers...
Hedge Funds Snapped Up ACADIA Pharmaceuticals Inc. (ACAD) Before The Q4 Rally
The market has been volatile in the last few months as the Federal Reserve finalized its rate cuts and uncertainty looms over trade negotiations with...
Hedge Funds Are Betting On ACADIA Pharmaceuticals Inc. (ACAD) Again
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on...
Hedge Fund and Insider Trading News: Ken Griffin, Tom Steyer, Amber Capital, Acadia Pharmaceuticals Inc. (ACAD), and More
Activist Amber Capital Locks Horns with Lagardere Over Lawsuit (Reuters) PARIS (Reuters) – Activist shareholder Amber Capital, which is being sued...
Is ACADIA Pharmaceuticals Inc. (ACAD) A Good Stock To Buy?
Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying before the Q4 market crash that the stock market is overvalued due...
Were Hedge Funds Right About Flocking Into ACADIA Pharmaceuticals Inc. (ACAD)?
Is ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours...
Is ACADIA Pharmaceuticals Inc. (ACAD) A Good Stock To Buy?
“Value has performed relatively poorly since the 2017 shift, but we believe challenges to the S&P 500’s dominance are mounting and resulting...
Hedge Fund and Insider Trading News: Crispin Odey, Third Point LLC, Criterion Capital, Twitter Inc (TWTR), ACADIA Pharmaceuticals Inc. (ACAD), and More
Crispin Odey’s Comeback Gets a Boost After Hedge Fund Surges (Bloomberg) Crispin Odey, whose bearish bets led to his hedge fund suffering three successive...
13D Filing: Baker Bros. Advisors and Acadia Pharmaceuticals Inc (NASDAQ:ACAD)
Baker Bros. Advisors purchased about 1.2 million shares of Acadia Pharmaceuticals Inc (NASDAQ:ACAD) for about $19 per share last week. Here is why the...
13D Filing: Baker Bros. Advisors and Acadia Pharmaceuticals Inc (ACAD)
Acadia Pharmaceuticals Inc (NASDAQ:ACAD): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros...
13D Filing: Baker Bros. Advisors and Acadia Pharmaceuticals Inc (ACAD)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 9 – SEC Filing SECURITIES AND EXCHANGE COMMISSION WASHINGTON...
Tesla Motors Inc (TSLA), Netflix, ACADIA Pharmaceuticals: This Hedge Fund Manager’s Top Stock Picks for 2017
Mott Capital Management is a long-only fund managed by Michael Kramer. The fund usually invests in stocks with a horizon of 3-5 years and seeks to provide...
Here is What Hedge Funds Think About ACADIA Pharmaceuticals Inc. (ACAD)
Looking for high-potential stocks? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what...
Johnson & Johnson (JNJ), ACADIA Pharmaceuticals Inc. (ACAD): Healthcare Experts at March Altus Like These and Other Healthcare Stocks’ Prospects
March Altus Capital Management is a Connecticut-based long/short equity hedge fund that primarily invests in healthcare stocks. The fund was started in...
Incyte Corporation (INCY), Seattle Genetics, Inc. (SGEN) & Two More: Top Healthcare Hedge Fund Loves These Stocks
Baker Bros. Advisors is a fund managed by Julian Baker and Felix Baker that mainly invests in biotechnology companies, and today we are going to take...
Acadia Pharmaceuticals (ACAD): Baker Bros. Advisors Buys More Shares
Julian Baker and Felix Baker, the managers of Baker Bros. Advisors, have taken advantage of Acadia Pharmaceuticals Inc (NASDAQ:ACAD) recently announced...
Why 2U, Take-Two, Acadia, Air Lease and Acxiom Are Making Headlines Today
U.S. stock indexes are up substantially in Friday trading, with the S&P 500 hitting record highs, driven by a surprisingly strong jobs report out...
Stumbling Biotech Stocks Spell Doom for Baker Bros. Advisors
While several hedge funds have suffered enormous losses this year due to their investments in biotech stocks, the performance of the leading biotech-focused...
Why These Five Stocks Are Gaining Ground Today
The US stocks rallied on Wednesday after the dovish comments from Federal Reserve Chairwoman Janet Yellen on Tuesday. Among the prominent stocks that...
Why Are These Five Stocks In Spotlight Today?
U.S. equities inched up on Monday after fresh data displayed that consumer spending rose marginally in February. The Commerce Department revealed that...
Healthcare-focused Baker Bros. Advisors’ Top Picks: Incyte, Alexion, ACADIA & More
Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker. The firm focuses on life science and biotechnology companies...
Top 5 Healthcare Bets of World-Class Baker Bros. Advisors
Baker Bros. Advisors is one of the most famous healthcare-focused equity hedge funds in the world today. It was founded in 2000 by brothers Julian Baker...
ACADIA Pharmaceuticals Inc. (ACAD): Are Hedge Funds Right About This Stock?
Out of thousands of stocks that are currently traded on the market, it is difficult to determine those that can really generate strong returns. Hedge...
Why Are These Four Stocks Making A Late Surge?
Shareholders of Amicus Therapeutics, Inc. (NASDAQ:FOLD), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Novavax, Inc. (NASDAQ:NVAX), and Diamond Offshore...
Superconductor Technologies, Inc. (SCON), Pfizer Inc. (PFE), ACADIA Pharmaceuticals Inc. (ACAD): Sabby Capital’s Latest Moves in Healthcare Sector
Hal Mintz‘s Sabby Capital has initiated a passive stake in Superconductor Technologies, Inc. (NASDAQ:SCON) according to a schedule 13G form filed...
ACADIA Pharmaceuticals Inc. (ACAD), Pfizer Inc. (PFE): Sabby Management Rewarded for Its Healthcare Picks
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) spiked nearly 18% during Tuesday’s intraday trading and hit a 52-week high of $46.48. The price action...
Newfield Exploration Co. (NFX), ACADIA Pharmaceuticals Inc. (ACAD): How Did Andreas Halvorsen’s Small-Cap Picks Perform in Q3?
Andreas Halvorsen‘s Viking Global is a fund with great returns over its 15-years old history. Since its foundation, Viking’s flagship fund...
Triumph Group Inc (TGI), Intercept Pharmaceuticals Inc (ICPT), Zynga Inc (ZNGA): Viking Global’s Top 5 Small-Cap Picks
Small-cap picks from individual funds might provide investors with attractive investment options. In this article we will look into Andreas Halvorsen’...
Baker Bros. Advisors’ Latest Moves Involve ACADIA Pharmaceuticals Inc. (ACAD) & Synageva Biopharma Corp (TRMS)
Julian Baker and Felix Baker’s hedge fund, Baker Bros. Advisors, has recently tweaked its holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) and...
Hedge Fund News: Bill Miller, Richard Perry & Alphonse Fletcher
Miller: No ‘extraordinary value’ left in US markets (InvestmentWeek) Legg Mason’s Bill Miller is struggling to find the ‘extraordinary...
Should You Buy Optimer Pharmaceuticals, Inc. (OPTR)?
Should Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) investors track the following data? At the moment, there are plenty of metrics investors can use to...
Celgene Corporation (CELG), Onyx Pharmaceuticals, Inc. (ONXX): Revelations From This Blazing Biotech
Blazing. Sizzling. On fire. They all describe Celgene Corporation (NASDAQ:CELG) pretty well these days. With all of the heat generated by this biotech...
Hedge Funds Are Dumping EXACT Sciences Corporation (EXAS)
Is it smart to be bullish on EXACT Sciences Corporation (NASDAQ:EXAS)? In the financial world, there are a multitude of gauges shareholders can use to...
Hedge Funds Are Buying ACADIA Pharmaceuticals Inc. (ACAD)
Is it smart to be bullish on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)? In the eyes of many of your fellow readers, hedge funds are viewed as overrated...
Do Hedge Funds and Insiders Love Halozyme Therapeutics, Inc. (HALO)?
Is Halozyme Therapeutics, Inc. (NASDAQ:HALO) a good investment? Now, according to many investors, hedge funds are seen as delayed, outdated financial...
Array Biopharma Inc (ARRY): Hedge Funds Are Bearish and Insiders Are Undecided, What Should You Do?
Is Array Biopharma Inc (NASDAQ:ARRY) a good investment? At the moment, there are many methods investors can use to analyze Mr. Market. Some of the most...
Clovis Oncology Inc (CLVS), ACADIA Pharmaceuticals Inc. (ACAD): Healthcare Companies to Watch Out For
Healthcare is the most happening industry these days with new drugs on the line and investors injecting cash into companies with greater speculative growth...
ACADIA Pharmaceuticals Inc. (ACAD), Rite Aid Corporation (RAD), Questcor Pharmaceuticals Inc (QCOR): Are Any Of These Top Performers A Sell?
I began using Motley Fool’s CAPS as a way to disclose when I purchased and sold stocks, and my 97.2 rating showcases my last 10 months. CAPS compares...
Onyx Pharmaceuticals, Inc. (ONXX), Alexion Pharmaceuticals, Inc. (ALXN): 3 Biotechs That Could Be Bought Out This Year
Buyout! The word gets biotech investors’ blood flowing and their hearts racing. Mere rumors that a biotech stock could get bought out can send shares...
ACADIA Pharmaceuticals Inc. (ACAD), Alnylam Pharmaceuticals, Inc. (ALNY) & Celldex Therapeutics, Inc. (CLDX): Buy These Biotech Companies for Long-Term Growth
According to IBISWorld, revenue of global biotechnology companies will surge to $262 billion this year, up by 12.7%, year-over-year. This growth is due...
Celldex Therapeutics, Inc. (CLDX), Cytokinetics, Inc. (CYTK): Are These Top Biotech Performers Still Worth Buying?
Only a handful of stocks have gained 200% in 2013, and five of those stocks are in the biotechnology industry. Perhaps you already own one, or maybe...
